Search - tctmd.com

Displaying 381 - 400 of 651

Sort: Relevancy | Date

News Daily News

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

Todd Neale

June 04, 2018

News Daily News

Hypertension During Pregnancy Linked With Subsequent A-fib in Women

Yael L. Maxwell

May 18, 2018

Presentation ECHO 2018

CMR for Valvular Heart Disease

Presenter: Omar Khalique

April 19, 2018

News Daily News

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Shelley Wood

April 13, 2018

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Caitlin E. Cox

March 19, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Daily News

One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk

L.A. McKeown

January 18, 2018

News Features

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Yael L. Maxwell

January 12, 2018

News Conference News AHA 2017

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Yael L. Maxwell

November 12, 2017

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

Presentation TCT 2017

RESOLVE/SAVORY: Critique and Unanswered Questions

Presenter: David J. Moliterno, Vinod H. Thourani, Mohamed Abdel-Wahab

November 01, 2017

Presentation TCT 2017

RESOLVE/SAVORY: Topline Findings and Practice Implications

Presenter: David J. Moliterno, Vinod H. Thourani, Lars Sondergaard

November 01, 2017

Presentation TCT 2017

SURTAVI Trial Critique and Unanswered Questions

Presenter: David J. Moliterno, Vinod H. Thourani, E. Murat Tuzcu

November 01, 2017

Presentation TCT 2017

SURTAVI: Topline Findings and Practice Implications

Presenter: David J. Moliterno, Vinod H. Thourani, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

REPRISE III: Critique and Unanswered Questions

Presenter: David J. Moliterno, Vinod H. Thourani, Davide Capodanno

November 01, 2017

Presentation TCT 2017

REPRISE III: Topline Findings and Practice Implications

Presenter: David J. Moliterno, Vinod H. Thourani, Ted Feldman

November 01, 2017

Presentation TCT 2017

Valvular Heart Disease Interventions: Take-home Messages

Presenter: Habib Gamra, Mohamed Ahmed Sobhy, Graham A. Cassel, E. Murat Tuzcu

October 29, 2017

Presentation TCT 2017

Valvular Heart Disease Interventions: Take-home Messages

Presenter: Habib Gamra, Mohamed Ahmed Sobhy, Graham A. Cassel, E. Murat Tuzcu

October 29, 2017

Presentation TCT 2017

Further Thoughts From the Experts

Presenter: Habib Gamra, Mohamed Ahmed Sobhy, Hazem Khamis, Dhaker Lahidheb

October 29, 2017

Advertisement

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

Hypertension During Pregnancy Linked With Subsequent A-fib in Women

CMR for Valvular Heart Disease

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Ticagrelor: Better Platelet Blockade Post-TAVR?

One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

RESOLVE/SAVORY: Critique and Unanswered Questions

RESOLVE/SAVORY: Topline Findings and Practice Implications

SURTAVI Trial Critique and Unanswered Questions

SURTAVI: Topline Findings and Practice Implications

REPRISE III: Critique and Unanswered Questions

REPRISE III: Topline Findings and Practice Implications

Valvular Heart Disease Interventions: Take-home Messages

Valvular Heart Disease Interventions: Take-home Messages

Further Thoughts From the Experts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content